Atlas Trials

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

Clinical trial NCT06043297 · COMPLETED

Trial details

NCT number
NCT06043297
Sponsor
Humanis Saglık Anonim Sirketi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Antithrombic Drug
Start date
2023-02-23
Primary completion
2023-03-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.